Developer docs
API playgroundTry for free, no card

Search company profiles

QliniQ

Full company profile

uuid000oodc

Namestring
QliniQ
Legal namestring
QliniQ B.V.
Company typeenum
Private
Founded yearint
2015
Descriptiontext

QliniQ B.V. is a Netherlands-based medical device and pharmaceutical distributor headquartered in Oldenzaal, operating since 2015 as the exclusive Dutch representative for several international manufacturers of medical devices and generic medicines (Stragen, VOE, Basic Pharma, CERES Pharma, Biodermis). The company's product portfolio spans three categories: VOE post-operative compression garments (including custom-made orders fulfilled through an in-house atelier and the VOE Slim shapewear line with embedded active ingredients); the Biodermis silicone scar treatment line (Xeragel silicone gel, Epiderm silicone sheets in multiple variants, and ProSil silicone gel stick); and generic pharmaceuticals distributed through Dutch pharmacies, including hormone tablets (Tibolon Mithra, Vagirux, Zarelle), topical preparations (Cortifil cream, Triamcinolone acetonide ointment), Dienogest Stragen, and the Fecotest diagnostic self-test. All distributed products are manufactured within the EU, primarily in the Netherlands, Germany, and Spain.

The company monetizes through wholesale pharmaceutical distribution to Dutch pharmacies under a pharmaceutical wholesale license and GDP certification held since January 2016, direct-to-consumer e-commerce sales of compression garments through its own webshop (postoperatievedrukkleding.nl), and insurance-reimbursed sales of Biodermis scar treatment products when prescribed by physicians with a Zorgverzekeraars Nederland indication form. On June 16, 2026, the company was fully acquired by Marksans Pharma (NSE: MARKSANS), a publicly listed Indian pharmaceutical company, serving as its European market entry vehicle alongside parallel subsidiary incorporations in Ireland and Canada.

QliniQ is led by Raymond Lansink (Representative) and operates with a lean team of 1-10 employees. The company is structured as a Dutch private limited company (B.V.) and is now a wholly-owned subsidiary of Marksans Pharma, with no institutional investment rounds prior to the strategic acquisition.

Short descriptiontext

QliniQ B.V. is a Dutch medical device and pharmaceutical distributor representing international manufacturers (VOE compression garments, Biodermis scar treatment, Stragen generics) for the Netherlands market through pharmacy wholesale, e-commerce, and insurance reimbursement channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOldenzaal, Netherlands
HQ citystring
Oldenzaal
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device distribution, pharmaceutical wholesale, post-operative compression garments, scar treatment products, generic medicines supply
Industry2 codes
PRIMARYCRAFAHAG
Medical, Dental & Lab Supply Marketplaces
Consumer Products & Retail/E-commerce & Marketplaces/Wholesale/B2B E-commerce Marketplaces
SECONDARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code3 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical device distribution
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical device distribution
TypeOne Time License
Description

Distribution of medical devices including post-operative compression clothing and scar treatment products through pharmacies and direct sales in the Netherlands

qliniqmedical.nl
2Pharmaceutical wholesale
TypeTransaction Fee
Description

Pharmaceutical wholesale distribution of generic medicines to pharmacies across the Netherlands, operating under GDP certification and pharmaceutical wholesale license obtained in 2016

qliniqmedical.nl
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Marketing or Sales, Personnel, Others
Pricing details1 tier
1Biodermis products with insurance reimbursement
ModelOtherBilling cadencePay-as-you-go
Notes

Biodermis silicone products are eligible for full reimbursement by Dutch health insurers when prescribed by a physician with proper indication form

qliniqmedical.nl
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1VOE
Description

Spanish post-operative compression clothing brand providing constant and long-lasting pressure for reduction of hematomas and swelling after various treatments.

qliniqmedical.nl
+2 more records
Core offering1 text field

QliniQ B.V. operates as a Netherlands-based distributor and representative of world-leading manufacturers of medical devices and medicines. The company distributes post-operative compression clothing (VOE brand), silicone scar treatment products (Biodermis brand), and generic pharmaceuticals (Farmaceuticals) to Dutch pharmacies and consumers through its own webshop and wholesale channels.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

QliniQ BV is a Dutch medical device and pharmaceutical distributor and wholesale supplier based in Oldenzaal, operating as a representative for several leading global manufacturers of medical devices and medicines. Its product portfolio spans three main categories: (1) VOE post-operative compression garments and VOE Slim slimming/shapewear garments with embedded active ingredients, distributed from Spain; (2) the Biodermis scar treatment line — including Xeragel (silicone gel), ProSil (silicone gel stick), and Epiderm (silicone sheets in multiple variants) — for treating hypertrophic and keloid scars; and (3) generic pharmaceuticals (Farmaceutische groothandel) including hormone tablets, topical creams, and diagnostic self-tests, distributed through Dutch pharmacy wholesalers. All products are manufactured within the EU, with the Netherlands, Germany, and Spain as primary production countries. The company is wholly owned by Marksans Pharma (acquired June 16, 2026).

Product and service4 records
1VOE Compression Clothing
CategoryPost-operative compression garments
Description

Post-operative compression garments manufactured by Spanish brand VOE, providing constant and prolonged pressure to reduce hematomas and swelling following surgical procedures such as liposuction, abdominoplasty, and mastopexy. Distributed to Dutch patients and consumers with custom-made orders fulfilled via in-house atelier.

2VOE Slim
CategorySlimming/shapewear garments
Description

Slimming garments made from elastic material with thousands of microcapsules woven into the fabric, releasing active ingredients including Caffeine, Retinol, Vitamin A, Ceramides, Vitamin E, and Aloe Vera gradually into the skin during wear. Distributed as a VOE sub-brand in the Netherlands.

3Biodermis Scar Treatment Products
CategorySilicone scar treatment medical devices
Description

Medical device line from Biodermis for preventing and treating hypertrophic and keloid scars. Includes Xeragel (100% silicone gel), Epiderm (silicone sheeting), and ProSil (silicone gel stick), distributed in the Netherlands and eligible for reimbursement through Dutch health insurers when prescribed with the proper indication form.

4QliniQ Farmaceuticals (Generic Medicines)
CategoryGeneric pharmaceutical wholesale
Description

Generic pharmaceutical products distributed under QliniQ's pharmaceutical wholesale license (held since January 2016 with GDP certification). Products include Tibolon Mithra tablets, Cortifil cream, Zarelle film-coated tablets, Vagirux, Triamcinolone acetonide ointment, Dienogest Stragen, and Fecotest diagnostic self-test, available through all pharmaceutical wholesalers in the Netherlands.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Stragen is one of the world's leading manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands. QliniQ distributes Stragen products including Dienogest Stragen 2mg pharmaceutical product.

2VOE
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

VOE is a Spanish brand of post-operative compression clothing represented by QliniQ B.V. in the Netherlands. QliniQ distributes VOE compression garments known for providing constant and prolonged pressure to reduce hematomas and swelling.

qliniqmedical.nl
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Basic Pharma is one of the manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands market.

4CERES Pharma
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

CERES Pharma is one of the manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands market.

qliniqmedical.nl
5Biodermis
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Biodermis is a global leader for over 20 years in scar treatment, represented by QliniQ B.V. in the Netherlands. Products include Xeragel (silicone gel), Epiderm (silicone sheeting), and ProSil (silicone gel stick) for hypertrophic and keloid scar treatment.

qliniqmedical.nl
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major Dutch distributor of medical devices and healthcare supplies, serving pharmacies, hospitals, and patients. Closest direct comparable to QliniQ's medical device distribution business in the same Dutch market.

TypeDirect peer
Description

Swedish wound care and scar management company offering Mepiform silicone scar sheets and other post-operative products. Directly competes with the Biodermis Epiderm line that QliniQ distributes and is a benchmark for the scar-treatment distribution space.

TypeRegional player
Description

Dutch specialty pharmaceutical company distributing niche and generic medicines through the Dutch pharmacy channel. Comparable to QliniQ's Farmaceuticals division and operates in the same domestic reimbursement environment.

TypeBroad incumbent
Description

German-based manufacturer and distributor of medical products including wound care, compression therapy, and surgical supplies. Overlaps with QliniQ's VOE compression and Biodermis scar treatment categories at a much broader scale.

TypeBroad incumbent
Description

Global medical device company with a strong portfolio in advanced wound care, ostomy, and post-operative products. Comparable to QliniQ's portfolio positioning around post-surgical patient care.

TypeBroad incumbent
Description

Danish medical device company specializing in ostomy, wound, and continence care products distributed through pharmacies and hospitals. Comparable to QliniQ as a broader medical device distributor in adjacent categories.

TypeBroad incumbent
Description

European pharmaceutical wholesaler and distributor serving pharmacies across multiple countries. Comparable to QliniQ's pharmaceutical wholesale operations but at much greater scale and geographic reach.

TypeBroad incumbent
Description

Global medical technology company with advanced wound management products including silicone-based scar therapies. Direct overlap with QliniQ's Biodermis scar treatment franchise at a much larger scale.

TypeBroad incumbent
Description

One of Europe's largest pharmaceutical distribution and wholesale groups, supplying pharmacies across the continent. Comparable to QliniQ's pharmaceutical wholesale stream as a large-scale channel peer.

10Sandoz
TypeBroad incumbent
Description

Global leader in generic pharmaceuticals and biosimilars. Comparable to QliniQ's generic pharmaceutical wholesale stream and representative of the upstream manufacturer dynamic that shapes QliniQ's procurement.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

QliniQ

Medical device distributionqliniqmedical.nl

QliniQ B.V. is a Dutch medical device and pharmaceutical distributor representing international manufacturers (VOE compression garments, Biodermis scar treatment, Stragen generics) for the Netherlands market through pharmacy wholesale, e-commerce, and insurance reimbursement channels.

What QliniQ does

QliniQ B.V. is a Netherlands-based medical device and pharmaceutical distributor headquartered in Oldenzaal, operating since 2015 as the exclusive Dutch representative for several international manufacturers of medical devices and generic medicines (Stragen, VOE, Basic Pharma, CERES Pharma, Biodermis). The company's product portfolio spans three categories: VOE post-operative compression garments (including custom-made orders fulfilled through an in-house atelier and the VOE Slim shapewear line with embedded active ingredients); the Biodermis silicone scar treatment line (Xeragel silicone gel, Epiderm silicone sheets in multiple variants, and ProSil silicone gel stick); and generic pharmaceuticals distributed through Dutch pharmacies, including hormone tablets (Tibolon Mithra, Vagirux, Zarelle), topical preparations (Cortifil cream, Triamcinolone acetonide ointment), Dienogest Stragen, and the Fecotest diagnostic self-test. All distributed products are manufactured within the EU, primarily in the Netherlands, Germany, and Spain.

The company monetizes through wholesale pharmaceutical distribution to Dutch pharmacies under a pharmaceutical wholesale license and GDP certification held since January 2016, direct-to-consumer e-commerce sales of compression garments through its own webshop (postoperatievedrukkleding.nl), and insurance-reimbursed sales of Biodermis scar treatment products when prescribed by physicians with a Zorgverzekeraars Nederland indication form. On June 16, 2026, the company was fully acquired by Marksans Pharma (NSE: MARKSANS), a publicly listed Indian pharmaceutical company, serving as its European market entry vehicle alongside parallel subsidiary incorporations in Ireland and Canada.

QliniQ is led by Raymond Lansink (Representative) and operates with a lean team of 1-10 employees. The company is structured as a Dutch private limited company (B.V.) and is now a wholly-owned subsidiary of Marksans Pharma, with no institutional investment rounds prior to the strategic acquisition.

QliniQ firmographics

Firmographics
Name
QliniQ
Legal name
QliniQ B.V.
Website
https://qliniqmedical.nl
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
QliniQ B.V. is a Dutch medical device and pharmaceutical distributor representing international manufacturers (VOE compression garments, Biodermis scar treatment, Stragen generics) for the Netherlands market through pharmacy wholesale, e-commerce, and insurance reimbursement channels.
Ownership category
akta.pro rank

QliniQ industry classification

Industry
Product category
Medical device distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYCRAFAHAG
Medical, Dental & Lab Supply Marketplaces
Consumer Products & Retail/E-commerce & Marketplaces/Wholesale/B2B E-commerce Marketplaces
SECONDARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Medical device distribution
  • Pharmaceutical wholesale
  • Post-operative compression garments
  • Scar treatment products
  • Generic medicines supply

Where QliniQ is headquartered

Location

Headquarters

HQ city
Oldenzaal
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

QliniQ business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Others

Revenue model

  1. Medical device distribution: Distribution of medical devices including post-operative compression clothing and scar treatment products through pharmacies and direct sales in the Netherlands
  2. Pharmaceutical wholesale: Pharmaceutical wholesale distribution of generic medicines to pharmacies across the Netherlands, operating under GDP certification and pharmaceutical wholesale license obtained in 2016

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goBiodermis products with insurance reimbursement

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

QliniQ product offering

Product offering

Core offering

QliniQ B.V. operates as a Netherlands-based distributor and representative of world-leading manufacturers of medical devices and medicines. The company distributes post-operative compression clothing (VOE brand), silicone scar treatment products (Biodermis brand), and generic pharmaceuticals (Farmaceuticals) to Dutch pharmacies and consumers through its own webshop and wholesale channels.

Product overview

QliniQ BV is a Dutch medical device and pharmaceutical distributor and wholesale supplier based in Oldenzaal, operating as a representative for several leading global manufacturers of medical devices and medicines. Its product portfolio spans three main categories: (1) VOE post-operative compression garments and VOE Slim slimming/shapewear garments with embedded active ingredients, distributed from Spain; (2) the Biodermis scar treatment line — including Xeragel (silicone gel), ProSil (silicone gel stick), and Epiderm (silicone sheets in multiple variants) — for treating hypertrophic and keloid scars; and (3) generic pharmaceuticals (Farmaceutische groothandel) including hormone tablets, topical creams, and diagnostic self-tests, distributed through Dutch pharmacy wholesalers. All products are manufactured within the EU, with the Netherlands, Germany, and Spain as primary production countries. The company is wholly owned by Marksans Pharma (acquired June 16, 2026).

Differentiator

Problem solved

Functional benefit

Brands

  • VOE: Spanish post-operative compression clothing brand providing constant and long-lasting pressure for reduction of hematomas and swelling after various treatments.
  • Biodermis
  • Farmaceuticals

Products and services

  • VOE Compression Clothing Post-operative compression garments manufactured by Spanish brand VOE, providing constant and prolonged pressure to reduce hematomas and swelling following surgical procedures such as liposuction, abdominoplasty, and mastopexy. Distributed to Dutch patients and consumers with custom-made orders fulfilled via in-house atelier.
  • VOE Slim Slimming garments made from elastic material with thousands of microcapsules woven into the fabric, releasing active ingredients including Caffeine, Retinol, Vitamin A, Ceramides, Vitamin E, and Aloe Vera gradually into the skin during wear. Distributed as a VOE sub-brand in the Netherlands.
  • Biodermis Scar Treatment Products Medical device line from Biodermis for preventing and treating hypertrophic and keloid scars. Includes Xeragel (100% silicone gel), Epiderm (silicone sheeting), and ProSil (silicone gel stick), distributed in the Netherlands and eligible for reimbursement through Dutch health insurers when prescribed with the proper indication form.
  • QliniQ Farmaceuticals (Generic Medicines) Generic pharmaceutical products distributed under QliniQ's pharmaceutical wholesale license (held since January 2016 with GDP certification). Products include Tibolon Mithra tablets, Cortifil cream, Zarelle film-coated tablets, Vagirux, Triamcinolone acetonide ointment, Dienogest Stragen, and Fecotest diagnostic self-test, available through all pharmaceutical wholesalers in the Netherlands.

Companies that use QliniQ

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles3 records

QliniQ technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

QliniQ partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • StragencoreChannel Partner/ Reseller/ DistributorStragen is one of the world's leading manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands. QliniQ distributes Stragen products including Dienogest Stragen 2mg pharmaceutical product.
  • VOEcoreChannel Partner/ Reseller/ DistributorVOE is a Spanish brand of post-operative compression clothing represented by QliniQ B.V. in the Netherlands. QliniQ distributes VOE compression garments known for providing constant and prolonged pressure to reduce hematomas and swelling.
  • Basic PharmaminorChannel Partner/ Reseller/ DistributorBasic Pharma is one of the manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands market.
  • CERES PharmaminorChannel Partner/ Reseller/ DistributorCERES Pharma is one of the manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands market.
  • BiodermiscoreChannel Partner/ Reseller/ DistributorBiodermis is a global leader for over 20 years in scar treatment, represented by QliniQ B.V. in the Netherlands. Products include Xeragel (silicone gel), Epiderm (silicone sheeting), and ProSil (silicone gel stick) for hypertrophic and keloid scar treatment.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

QliniQ competitors and assessment

Company assessment

Direct peers

  • Mediq: Major Dutch distributor of medical devices and healthcare supplies, serving pharmacies, hospitals, and patients. Closest direct comparable to QliniQ's medical device distribution business in the same Dutch market.
  • Mölnlycke Health Care: Swedish wound care and scar management company offering Mepiform silicone scar sheets and other post-operative products. Directly competes with the Biodermis Epiderm line that QliniQ distributes and is a benchmark for the scar-treatment distribution space.

Regional players

  • Eurocept Pharmaceuticals: Dutch specialty pharmaceutical company distributing niche and generic medicines through the Dutch pharmacy channel. Comparable to QliniQ's Farmaceuticals division and operates in the same domestic reimbursement environment.

Broad incumbents

  • Hartmann Group: German-based manufacturer and distributor of medical products including wound care, compression therapy, and surgical supplies. Overlaps with QliniQ's VOE compression and Biodermis scar treatment categories at a much broader scale.
  • ConvaTec: Global medical device company with a strong portfolio in advanced wound care, ostomy, and post-operative products. Comparable to QliniQ's portfolio positioning around post-surgical patient care.
  • Coloplast: Danish medical device company specializing in ostomy, wound, and continence care products distributed through pharmacies and hospitals. Comparable to QliniQ as a broader medical device distributor in adjacent categories.
  • Alliance Healthcare: European pharmaceutical wholesaler and distributor serving pharmacies across multiple countries. Comparable to QliniQ's pharmaceutical wholesale operations but at much greater scale and geographic reach.
  • Smith & Nephew: Global medical technology company with advanced wound management products including silicone-based scar therapies. Direct overlap with QliniQ's Biodermis scar treatment franchise at a much larger scale.
  • Phoenix Group: One of Europe's largest pharmaceutical distribution and wholesale groups, supplying pharmacies across the continent. Comparable to QliniQ's pharmaceutical wholesale stream as a large-scale channel peer.
  • Sandoz: Global leader in generic pharmaceuticals and biosimilars. Comparable to QliniQ's generic pharmaceutical wholesale stream and representative of the upstream manufacturer dynamic that shapes QliniQ's procurement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

QliniQ social profiles

Digital presence

QliniQ compliance and trust

Trust signal

Compliance1 record

QliniQ financial estimates

Financial estimate

Revenue estimate

Valuation estimate

QliniQ leadership team

Management profile

Number of profiles

Profiles1 record

QliniQ funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

QliniQ M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QliniQ

What does QliniQ do?

QliniQ B.V. operates as a Netherlands-based distributor and representative of world-leading manufacturers of medical devices and medicines. The company distributes post-operative compression clothing (VOE brand), silicone scar treatment products (Biodermis brand), and generic pharmaceuticals (Farmaceuticals) to Dutch pharmacies and consumers through its own webshop and wholesale channels.

Is QliniQ a public or private company?

QliniQ is a private company. It is classified as corporate owned and is currently operating.

When was QliniQ founded?

QliniQ was founded in 2015. It employs 1 to 10 people.

Where is QliniQ based?

QliniQ is headquartered in Oldenzaal, Netherlands, in the Europe region.

How does QliniQ make money?

Two revenue lines are on record. Medical device distribution is the primary driver. The others are pharmaceutical wholesale.

Who are QliniQ's main competitors?

Direct peers on record are Mediq and Mölnlycke Health Care. Eurocept Pharmaceuticals is listed as a regional player. Broad incumbents are Hartmann Group, ConvaTec, Coloplast, Alliance Healthcare, Smith & Nephew, Phoenix Group and Sandoz.

Does QliniQ have an API?

No public API is recorded for QliniQ.

What industry is QliniQ in?

QliniQ's product category is Medical device distribution. Its primary akta.pro industry code is CRAFAHAG, Medical, Dental & Lab Supply Marketplaces, with a secondary code of HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales